CLINICAL TRIALS PROFILE FOR BUSPAR
✉ Email this page to a colleague
All Clinical Trials for BUSPAR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00174226 ↗ | Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar | Completed | Pfizer | Phase 2 | 2004-11-01 | Determine if there is a difference in treatment response for adults with ADHD who are treated with Strattera versus those treated with a combination of Strattera and buspirone |
NCT00178971 ↗ | Serotonin 1A Agonists and Cognition in Schizophrenia | Completed | National Alliance for Research on Schizophrenia and Depression | Phase 3 | 2003-01-01 | Examines cognitive functioning in patients with schizophrenia or schizoaffective disorder who have been treated with antipsychotic medications. Patients will be assigned to take active medication (Buspar)or placebo along with their prescribed antipsychotic medication for six weeks. Patients' memory and problem-solving ability will be tested before and after medication. |
NCT00178971 ↗ | Serotonin 1A Agonists and Cognition in Schizophrenia | Completed | Northwestern University | Phase 3 | 2003-01-01 | Examines cognitive functioning in patients with schizophrenia or schizoaffective disorder who have been treated with antipsychotic medications. Patients will be assigned to take active medication (Buspar)or placebo along with their prescribed antipsychotic medication for six weeks. Patients' memory and problem-solving ability will be tested before and after medication. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BUSPAR
Condition Name
Clinical Trial Locations for BUSPAR
Trials by Country
Clinical Trial Progress for BUSPAR
Clinical Trial Phase
Clinical Trial Sponsors for BUSPAR
Sponsor Name